ResMed, Inc. (RMD)
250.47
-4.85
(-1.90%)
USD |
NYSE |
Mar 06, 10:16
ResMed Market Cap : 36.49B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 105.68B |
| Abbott Laboratories | 189.25B |
| Baxter International, Inc. | 9.070B |
| Stryker Corp. | 136.92B |
| Globus Medical, Inc. | 11.56B |
Market Cap Related Metrics
| PE Ratio | 24.76 |
| PS Ratio | 6.815 |
| PEG Ratio | 1.269 |
| Price to Book Value | 5.773 |
| Price to Free Cash Flow | 20.71 |
| Price | 250.47 |
| Earnings Yield | 4.04% |
| PEGY Ratio | 1.212 |
| Operating PE Ratio | 19.93 |
| Normalized PE Ratio | 24.51 |